Debt-to-equity of Matinas BioPharma Holdings, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Matinas BioPharma Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Matinas BioPharma Holdings, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 64%, a 108% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Matinas BioPharma Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 64% +33% +108% 30 Sep 2025
Q2 2025 52% +22% +73% 30 Jun 2025
Q1 2025 43% +15% +53% 31 Mar 2025
Q4 2024 35% +12% +50% 31 Dec 2024
Q3 2024 31% +8.4% +38% 30 Sep 2024
Q2 2024 30% +8.7% +41% 30 Jun 2024
Q1 2024 28% +6.5% +30% 31 Mar 2024
Q4 2023 24% +2.6% +13% 31 Dec 2023
Q3 2023 22% +2.6% +14% 30 Sep 2023
Q2 2023 21% +3.8% +22% 30 Jun 2023
Q1 2023 21% +6.6% +45% 31 Mar 2023
Q4 2022 21% +8.3% +66% 31 Dec 2022
Q3 2022 20% +8% +70% 30 Sep 2022
Q2 2022 18% +7.3% +71% 30 Jun 2022
Q1 2022 15% +5.2% +55% 31 Mar 2022
Q4 2021 13% +3.2% +34% 31 Dec 2021
Q3 2021 11% +0.91% +8.6% 30 Sep 2021
Q2 2021 10% -1.9% -16% 30 Jun 2021
Q1 2021 9.5% -5.4% -36% 31 Mar 2021
Q4 2020 9.4% -9.6% -50% 31 Dec 2020
Q3 2020 11% -8.4% -44% 30 Sep 2020
Q2 2020 12% -9.1% -43% 30 Jun 2020
Q1 2020 15% -8.2% -35% 31 Mar 2020
Q4 2019 19% -12% -38% 31 Dec 2019
Q3 2019 19% -15% -45% 30 Sep 2019
Q2 2019 21% -10% -33% 30 Jun 2019
Q1 2019 23% -4.7% -17% 31 Mar 2019
Q4 2018 31% +7.5% +33% 31 Dec 2018
Q3 2018 34% +12% +53% 30 Sep 2018
Q2 2018 32% +9.6% +43% 30 Jun 2018
Q1 2018 28% -1.3% -4.3% 31 Mar 2018
Q4 2017 23% -22% -49% 31 Dec 2017
Q3 2017 23% -23% -50% 30 Sep 2017
Q2 2017 22% -29% -57% 30 Jun 2017
Q1 2017 29% -13% -31% 31 Mar 2017
Q4 2016 45% +2.4% +5.8% 31 Dec 2016
Q3 2016 45% +1.4% +3.1% 30 Sep 2016
Q2 2016 51% +11% +27% 30 Jun 2016
Q1 2016 42% +9.8% +30% 31 Mar 2016
Q4 2015 42% +25% +146% 31 Dec 2015
Q3 2015 44% +32% +279% 30 Sep 2015
Q2 2015 40% 30 Jun 2015
Q1 2015 33% 31 Mar 2015
Q4 2014 17% 31 Dec 2014
Q3 2014 12% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.